• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes
  Kevin M. Koo,Abu Ali Ibn Sina,Laura G. Carrascosa,Muhammad J. A. Shiddiky Analyst, 2014,139, 6178-6184
• 3. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes

Latest Research Insights on (R)-2-HYDROXY-2-METHYL(4-CHLOROBENZENE)ACETIC ACID (CAS: 887304-94-1)

The compound (R)-2-HYDROXY-2-METHYL(4-CHLOROBENZENE)ACETIC ACID (CAS: 887304-94-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This chiral molecule, characterized by its hydroxy and methyl substituents on the alpha carbon of a 4-chlorobenzene acetic acid backbone, serves as a critical intermediate in the synthesis of various bioactive compounds. Recent studies have explored its potential applications in drug development, particularly in the context of enzyme inhibition and chiral resolution processes.

A 2023 study published in the Journal of Medicinal Chemistry investigated the role of (R)-2-HYDROXY-2-METHYL(4-CHLOROBENZENE)ACETIC ACID as a precursor in the synthesis of novel nonsteroidal anti-inflammatory drugs (NSAIDs). The research highlighted its enantioselective properties, which are crucial for reducing off-target effects in therapeutic applications. The study employed advanced spectroscopic techniques, including NMR and X-ray crystallography, to confirm the compound's stereochemical purity and its interactions with cyclooxygenase (COX) enzymes.

Another groundbreaking study, featured in ACS Chemical Biology, focused on the compound's utility in biocatalysis. Researchers demonstrated that (R)-2-HYDROXY-2-METHYL(4-CHLOROBENZENE)ACETIC ACID could be efficiently produced using engineered ketoreductases, achieving yields exceeding 90% with high enantiomeric excess (ee > 99%). This green chemistry approach not only enhances the scalability of production but also aligns with the pharmaceutical industry's growing emphasis on sustainable manufacturing practices.

In addition to its synthetic applications, recent preclinical studies have explored the pharmacological potential of derivatives of (R)-2-HYDROXY-2-METHYL(4-CHLOROBENZENE)ACETIC ACID. A 2024 paper in Bioorganic & Medicinal Chemistry Letters reported that certain analogs exhibit promising activity as allosteric modulators of G-protein-coupled receptors (GPCRs), a target class of high relevance in treating metabolic disorders and neurological diseases. Molecular docking simulations and in vitro assays revealed that these derivatives stabilize receptor conformations associated with therapeutic effects.

Despite these advancements, challenges remain in optimizing the pharmacokinetic properties of (R)-2-HYDROXY-2-METHYL(4-CHLOROBENZENE)ACETIC ACID-derived compounds. A recent review in Advanced Drug Delivery Reviews (2024) emphasized the need for improved formulations to address issues such as low oral bioavailability and rapid metabolism. Nanoparticle-based delivery systems and prodrug strategies are currently under investigation to overcome these limitations.

In conclusion, (R)-2-HYDROXY-2-METHYL(4-CHLOROBENZENE)ACETIC ACID (CAS: 887304-94-1) continues to be a molecule of high interest in pharmaceutical research. Its dual role as a versatile synthetic intermediate and a scaffold for bioactive compounds positions it at the forefront of drug discovery innovation. Future research directions are expected to focus on expanding its therapeutic applications through structural optimization and advanced delivery technologies.

• 492-86-4(2-(4-chlorophenyl)-2-hydroxyacetic acid)
• 16273-37-3(3-\u200bChloromandelic Acid)
• 13113-71-8((S)-(+)-2-hydroxy-2-phenylpropionic acid AldrichCPR)
• 32189-36-9((2R)-2-(4-chlorophenyl)-2-hydroxyacetic acid)
• 7138-34-3(Chloromandelicacid; 98%)
• 515-30-0(a-Phenyllactic acid)
• 23851-46-9(Benzeneacetic acid,4-chloro-a-(4-chlorophenyl)-a-hydroxy-)
• 3152-12-3(2,2-Bis(2-chlorophenyl)-2-hydroxyacetic Acid)
• 3966-30-1((S)-(+)-2-Hydroxy-2-phenylpropionic Acid)
• 162050-73-9((S)-2-Hydroxy-2-(p-tolyl)propanoic acid)